Fig. 10From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysisGEPIA2 expression analysis of MTRNR2L8 revealed that there is no significant difference between the expression levels of this gene in the different stages of breast cancer and gastric cancer samplesBack to article page